Virax Biolabs VRAX
NASDAQ VRAX
$1.34 -0.03 (-2.19%)
At close: Oct 21, 2026 · 4:00 PM EDT

Virax Biolabs (VRAX) Short term Debt (2024 - 2026)

Updated

Virax Biolabs' Short term Debt came in at $28,477 for fiscal Q4 2026 (quarter ended Mar 31, 2026), down 12.3% from $32,468 a year earlier.

Analysis

Virax Biolabs (VRAX) Short term Debt (2024 - 2026) Analysis & Trends

Going back to fiscal Q2 2025, Virax Biolabs' Short term Debt data covers 4 quarters.

  • Going back by fiscal year, Short term Debt was $32,468 in FY2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Virax Biolabs 536,746.51 -20.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 28,477.00
Sep 30, 2025 195,577.00
Mar 31, 2025 32,468.00
Sep 30, 2024 222,728.00
API Access

Virax Biolabs Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=VRAX&period=max&api_key=YOUR_API_KEY